Do Quoc-Tuan, Bernard Philippe
Greenpharma SA, 3 Allée de Titane, 45100 Orléans, France.
IDrugs. 2004 Nov;7(11):1017-27.
Combinatorial chemistry and high-throughput screening (HTS) have led to the identification of numerous agents that are active and selective in vitro. Identifying drugs that are active in vivo, however, remains a challenge. Traditional medicinal cures based on natural materials have proven useful for many populations worldwide, representing huge and disperse tracts of knowledge that are sometimes neglected in Western research due to differences in the concepts of illness. In this review we introduce a new approach, termed 'reverse pharmacognosy' (from diverse molecules to plants), which can be coupled with pharmacognosy (from biodiverse plants to molecules). Reverse pharmacognosy utilizes new techniques, such as HTS, virtual screening and a knowledge database containing the traditional uses of plants. Integrating pharmacognosy and reverse pharmacognosy in the research process may provide an efficient and rapid tool for natural drug discovery.
组合化学和高通量筛选(HTS)已促成了众多在体外具有活性和选择性的药物的发现。然而,确定在体内具有活性的药物仍然是一项挑战。基于天然材料的传统药物疗法已被证明对全球许多人群有用,代表着庞大而分散的知识领域,由于疾病概念的差异,这些知识有时在西方研究中被忽视。在本综述中,我们介绍了一种新方法,称为“反向生药学”(从多样分子到植物),它可以与生药学(从生物多样的植物到分子)相结合。反向生药学利用新技术,如高通量筛选、虚拟筛选以及包含植物传统用途的知识数据库。在研究过程中将生药学和反向生药学相结合,可能为天然药物发现提供一种高效且快速的工具。